Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism

被引:0
|
作者
Tomasz Hryszko
Szymon Brzosko
Alicja Rydzewska-Rosolowska
Ewa Koc-Zorawska
Michal Mysliwiec
机构
[1] Medical University of Bialystok,Department of Nephrology and Transplantation
来源
关键词
Bone metabolism; Cinacalcet; FGF-23; Hemodialysis; Secondary hyperparathyroidism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1479 / 1486
页数:7
相关论文
共 50 条
  • [31] Effect of Cinacalcet Combined with Calcitriol on the Clinical Outcome and Bone Metabolism in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism
    Yuan, Fang
    Chen, Xing
    Wang, Chang
    Li, Zheng
    Liu, Hong
    BLOOD PURIFICATION, 2018, 45 (1-3) : 73 - 78
  • [32] Impact of cinacalcet HCL on bone remodeling and minimodeling in patients with secondary hyperparathyroidism
    Yajima, A.
    Takahashi, H. E.
    Akizawa, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S356 - S356
  • [33] TREATMENT WITH CINACALCET INCREASES PLASMA ADIPONECTIN CONCENTRATION IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    ENDOCRINE PRACTICE, 2015, 21 (07) : 743 - 749
  • [34] Circulating fibroblast growth factor-23 (FGF-23) levels predict the development of secondary hyperparathyroidism in long term dialysis patients.
    Kazama, JJ
    Gejyo, F
    Shigematsu, T
    Fukumoto, S
    Yamashita, T
    Nakanishi, S
    Fukagawa, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 209A - 209A
  • [35] Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism
    Tsuruta, Yuki
    Okano, Kazuhiro
    Kikuchi, Kan
    Tsuruta, Yukio
    Akiba, Takashi
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (01) : 120 - 126
  • [36] Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism
    Yuki Tsuruta
    Kazuhiro Okano
    Kan Kikuchi
    Yukio Tsuruta
    Takashi Akiba
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2013, 17 : 120 - 126
  • [37] Long-Term Cinacalcet HCl Treatment Improved Bone Metabolism in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism
    Shigematsu, Takashi
    Akizawa, Tadao
    Uchida, Eiji
    Tsukamoto, Yusuke
    Iwasaki, Manabu
    Koshikawa, Shouzo
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 230 - 236
  • [38] Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism
    Ishimura, E.
    Okuno, S.
    Tsuboniwa, N.
    Ichii, M.
    Yamakawa, K.
    Yamakawa, T.
    Shoji, S.
    Nishizawa, Y.
    Inaba, M.
    CLINICAL NEPHROLOGY, 2011, 76 (04) : 259 - 265
  • [39] An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism
    Malluche, H. H.
    Monier-Faugere, M. -C.
    Wang, G.
    Frazao, J. M.
    Charytan, C.
    Coburn, J. W.
    Coyne, D. W.
    Kaplan, M. R.
    Baker, N.
    McCary, L. C.
    Turner, S. A.
    Goodman, W. G.
    CLINICAL NEPHROLOGY, 2008, 69 (04) : 269 - 278
  • [40] COMPARATIVE STUDY BETWEEN THE IMPACT OF ETELCALCETIDE AND CINACALCET ON LEVELS OF IPTH, FGF-23, KLOTHO PROTEIN, SCLEROSTIN, CA AND P IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM. RESULTS FROM A PROSPECTIVE RANDOMIZED TRIAL
    Shutov, Evgeny
    Kotlyarova, Galina
    Lysenko, Ksenia
    Ryabinskaya, Galina
    Lashutin, Sergey
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36